-
Bausch and Lomb Opcon-A Eye Allergy Relief
08 May 2024 15:33 GMT
… Opcon-A. I know that Bausch + Lomb is an American-Canadian company …
-
A look at Don & Bob's restaurant circa the 1980s. Plus, more rarely seen photos of Rochester
12 May 2024 13:37 GMT
Don & Bob's, 2075 Monroe Ave., Brighton, is hopping during lunch hour in this May 1982 photo.Jim LaragyThis 1982 photo shows the interior of Vic & Irv's restaurant.REED HOFFMANN, StaffThe “Can of Worms,” as it was popularly known before it …
-
VIDEO: Suprachoroidal acetonide shows durability at 6 months in uveitic macular edema
11 May 2024 19:50 GMT
… .
Disclosures:
Singer reports consulting for Bausch + Lomb.
Add topic to email alerts …
-
Human Microchipping Market Size Estimated to Surge USD 2.54 billion Growth by 2032, Exhibit a CAGR of 6.1%
10 May 2024 04:54 GMT
… , Advanced Microlabs, Boston Scientific Corporation, Bausch and Lomb, PSivida Pharmaceutical Inc., Delpor Inc …
-
R3 Vascular secures funding to support bioresorbable scaffold trial
10 May 2024 13:39 GMT
Medical device company R3 Vascular has successfully closed an $87m Series B financing round led by affiliates of Deerfield Management, to support a trial of its bioresorbable scaffold, MAGNITUDE.
The financing round saw participation from existing …
-
Exeter High School names top 10 students in the Class of 2024
10 May 2024 12:58 GMT
… activities.
Annastina was awarded the Bausch+Lomb Honorary Science Award her junior …
-
Salix adds melody to Xifaxan campaign, running TV spot with 'Scandal' actor Bellamy Young
10 May 2024 11:14 GMT
… from the eye health business Bausch + Lomb. Amneal Pharmaceuticals is also targeting …
-
Mastering New-Technology Lenses
10 May 2024 07:19 GMT
… FDA, the Apthera IOL (Bausch + Lomb) and the EVO+ ICL … AcuFocus before being acquired by Bausch + Lomb, the Apthera (originally … for Bausch + Lomb. Dr. Vukich is a consultant for Bausch + Lomb and … Wiley is a consultant for Bausch + Lomb and STAAR Surgical.
1 …
-
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
09 May 2024 17:45 GMT
… , through our controlling interest in Bausch + Lomb. Our ambition is to be …
-
R3 Vascular Announces $87 Million in Series B Financing
09 May 2024 18:44 GMT
Summation
We would also like to acknowledge the significant accomplishments of our founder Kamal Ramzipoor who has worked tirelessly to establish R3 Vascular as a leader in the development and manufacturing of fully bioresorbable vascular scaffolds.
“I …